Arslan Inayat

Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Introduction:Multiple Myeloma (MM) cells show resistance to standard therapies due to overexpression of the transport protein, Exportin 1. Selinexor is a novel drug that targets the Expor...

Maham Babar ;

Madeeha S. Waleed ;

Arslan Inayat ;

Danish Safi ;

Anum Babar ;

Hina Zubair ;

Mainoma Bano ;

Sana Rafique ;

Arzu Shahid ;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Arslan Inayat

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products